FEMY (Femasys) Short Percentage of Float


FEMY Femasys Inc FEMY
55 GF Score
Price $3.80
GF Value $12.22
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Femasys Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FEMY vs RVP, HBIO, ZJYL: Short Percentage of Float Comparison

For the Medical Instruments & Supplies subindustry, Femasys's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femasys Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Femasys's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Femasys's Short Percentage of Float falls into.


FEMY
55GF Score
Femasys Inc FEMY
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Femasys (FEMY) Overvalued in 2026?

Based on GuruFocus' analysis, Femasys stock appears to be undervalued. The current stock price of $3.80 is trading 68.9% below its estimated GF Value™ of $12.22. GuruFocus considers Femasys to be Possible Value Trap.

Key valuation signals for FEMY:

  • Short Percentage of Float:
  • GF Value™: $12.22 vs. price of $3.80 (68.9% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the FEMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Femasys Business Description

Address 3950 Johns Creek Court, Suite 100, Suwanee, GA, USA, 30024
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
55GF Score

Get the complete analysis for FEMY

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.80
Price
$12.22
GF Value